News from sequana medical ag A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

16 May, 2018, 09:00 BST Sequana Medical Announces Inclusion of alfapump® in EASL Clinical Practice Guidelines and Presentation of Study Demonstrating Physical Component of QOL is Predictor of Mortality in Refractory Ascites

Sequana Medical AG ("Sequana Medical"), a commercial stage medical device company and an innovator in the management of liver disease & malignant...


19 Mar, 2018, 09:00 GMT Sequana Medical Announces Publication of Results of Multicentre Randomized Controlled Study: Patients with Refractory Ascites Treated with alfapump® System have Better Health-Related Quality of Life as Compared to Those Treated with Large Volume Paracentesis

Sequana Medical AG ("Sequana Medical"), a commercial stage medical device company and an innovator in the management of liver disease, announces the...


24 Oct, 2017, 09:01 BST Sequana Medical Announces Results of the MOSAIC Trial Data Presented at 2017 AASLD

Sequana Medical AG (Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, today announced...


19 Oct, 2017, 09:00 BST Sequana Medical Announces 2017 AASLD Poster Presentation

Sequana Medical AG (Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, today announced...


04 Oct, 2017, 09:00 BST Sequana Medical Announces Publication of Results of alfapump® Multicentre, Post-Marketing Surveillance Registry in Alimentary Pharmacology & Therapeutics (AP&T)

Sequana Medical AG (Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, announces the...


06 Jul, 2017, 08:30 BST Sequana Medical Announces Publication of Results of Multicentre Randomized Controlled Study for the alfapump® vs. Large Volume Paracentesis for Refractory Ascites in Journal of Hepatology

Sequana Medical AG ("Sequana Medical), a commercial stage medical device company and an innovator in the management of liver disease, announces the...


22 Dec, 2016, 07:00 GMT Sequana Medical Announces Sudden Passing of Founder, President & CEO; Ian Crosbie Appointed Chief Executive Officer

The Board of Directors of Sequana Medical AG ("Sequana Medical" or the "Company") announces with great sadness, the sudden death of its Founder,...


11 Jul, 2016, 10:27 BST Ian Crosbie Joins Sequana Medical as Chief Financial Officer

Sequana Medical AG, a privately held medical device company focused on the development and commercialization of innovative, implantable pump systems...


01 Jul, 2016, 07:00 BST Former Bayer and Pharmacia Senior Executive Rolf A. Classon Joins the Sequana Medical AG Board as Chairman

Sequana Medical AG, a privately held medical device company focused on the development and commercialization of innovative, implantable pump systems...


14 Apr, 2016, 06:00 BST Sequana Medical Announces First Satellite Symposium and Key Data from its European Randomized Controlled Trial of the alfapump® System to be Presented at The International Liver Congress™ (ILC) 2016 in Barcelona, Spain, on 16 April 2016

Sequana Medical AG, a privately held medical device company focused on the development and commercialization of innovative, implantable pump systems...


23 Oct, 2015, 06:00 BST Sequana Medical AG Raises CHF 9 million (USD 9.3M) in a Series C Extension

Sequana Medical AG, a privately held medical device company focused on the development and commercialization of innovative implantable pump systems...


05 Nov, 2014, 06:00 GMT World First, as Patient Receives an Implanted Pump System to Manage Pleural Effusions

Swiss company's innovative technology enables the automated management of excess fluid around the lungs for the first time ever. Sequana Medical AG,...


28 Apr, 2014, 06:00 BST Sequana Medical AG Raises CHF 23 Million in a Series C Financing Led by LSP, and Adds an Independent Board Chairman and Vice President of Sales and Marketing

Sequana Medical AG, a private Swiss medical device company with innovative fluid management technologies, announced today that it has raised CHF 23...


30 Oct, 2012, 11:00 GMT Sequana Medical Receives CE-Mark Approval for the use of its alfapump® System in Cancer Patients With Malignant ascites

Sequana Medical is pleased to announce that it has received CE mark approval for use of its alfapump® system in patients with ascites caused by...


01 Mar, 2012, 06:00 GMT Sequana Medical's ALFApump® System Receives Reimbursement in Germany for Breakthrough Technology in Ascites Management

NUB Grants Approval for Fifteen Leading Hepatology Centres in Germany. Sequana Medical announced today that its ALFApump® System has received German...


09 Dec, 2011, 06:00 GMT NHS National Innovation Centre Estimates Sequana Medical's ALFApump® System Could Save the NHS £50 Million in ascites Care Annually

NHS National Innovation Centre supports the cost effectiveness of Sequana Medical's ALFApump System Sequana Medical announced today the findings of...


04 Nov, 2011, 10:38 GMT The Medical University of Vienna and Vienna General Hospital Perform the First two Commercial Implants Worldwide of Sequana Medical's ALFApump® System

Major milestone achieved in the commercial launch of new technology in the treatment of patients with refractory ascites due to liver cirrhosis....


13 Jul, 2011, 06:00 BST Sequana Medical Receives CE Mark Approval for the ALFApump™ System and Adds Key Executive to Team

New Technology Expands Treatment Options for Patient With Refractory Ascites Due to Liver Cirrhosis. Dr. Farzana Malik Joins as Vice President of...